Martin Misch
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
- Genetics 30
- Glioma Diagnosis and Treatment 30
-
- Brain Metastases and Treatment 9
- Cancer-related cognitive impairment studies 2
- Co-authors
- Peter Vajkoczy (24 shared papers)Florian Stockhammer (5 shared papers)Arend Koch (6 shared papers)Julia Onken (18 shared papers)Michail Plotkin (3 shared papers)Andreas von Deimling (2 shared papers)Christian Johannes Hartmann (2 shared papers)Thomas Picht (7 shared papers)
- Journals
- Journal of Neuro-Oncology (9 papers)Neuro-Oncology (4 papers)Acta Neurochirurgica (3 papers)Radiation Oncology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- GermanySwitzerlandAustria
In The Last Decade
Martin Misch
47 papers receiving 2.1k citations
Martin Misch's Hit Papers
Peers
Comparison fields: 5 of 99
- Genetics 1.2k
- Cancer Research 251
- Neurology 226
- Oncology 290
- Immunology 233
Countries citing papers authored by Martin Misch
This map shows the geographic impact of Martin Misch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Misch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Misch more than expected).
Fields of papers citing papers by Martin Misch
This network shows the impact of papers produced by Martin Misch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Misch. The network helps show where Martin Misch may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Misch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 431 |
| 2 | A vaccine targeting mutant IDH1 in newly diagnosed glioma Hit paper breakdown → | 2021 | 330 |
| 3 | 2015 | 217 | |
| 4 | 2012 | 120 | |
| 5 | 2022 | 106 | |
| 6 | 2022 | 61 | |
| 7 | 2009 | 58 | |
| 8 | 2019 | 56 | |
| 9 | 2012 | 55 | |
| 10 | 2010 | 50 | |
| 11 | 2015 | 46 | |
| 12 | 2014 | 40 | |
| 13 | 2021 | 39 | |
| 14 | 2021 | 36 | |
| 15 | 2019 | 34 | |
| 16 | 2021 | 33 | |
| 17 | 2022 | 33 | |
| 18 | 2020 | 32 | |
| 19 | 2018 | 30 | |
| 20 | 2020 | 28 |
About Martin Misch
Martin Misch is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Neurology, Oncology and Cancer Research, having authored 57 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (30 papers), Brain Metastases and Treatment (9 papers), Meningioma and schwannoma management (6 papers), Surgical Simulation and Training (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Genomics and Diagnostics (2 papers), CAR-T cell therapy research (2 papers) and Cancer-related cognitive impairment studies (2 papers). The work is most often cited by research in Genetics (1.2k citations), Cancer Research (251 citations), Neurology (226 citations), Oncology (290 citations) and Immunology (233 citations). Martin Misch has collaborated with scholars based in Germany, Switzerland and Austria. Frequent co-authors include Peter Vajkoczy, Florian Stockhammer, Arend Koch, Julia Onken, Michail Plotkin, Andreas von Deimling, Christian Johannes Hartmann, Thomas Picht, Dietmar Krex and Florian A. Ringel. Their work appears in journals such as Journal of Neuro-Oncology, Neuro-Oncology, Acta Neurochirurgica, Radiation Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.